Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	41,569	46,246	46,128	80,883	56,859	48,657
Market Cap Growth	-5.61%	0.25%	-42.97%	42.25%	16.86%	51.96%
Enterprise Value	37,888	45,142	45,077	79,772	56,254	47,971
Last Close Price	70.48	76.25	74.61	129.55	91.23	77.76
PE Ratio	27.18	32.98	30.31	53.81	69.05	46.48
Forward PE	29.78	28.45	30.35	52.98	43.34	38.53
PS Ratio	6.71	7.70	8.57	15.46	12.96	11.19
PB Ratio	4.35	6.88	7.94	13.86	12.43	11.73
P/TBV Ratio	5.69	9.31	10.59	18.62	18.52	18.40
P/FCF Ratio	80.64	71.94	47.38	57.51	87.84	52.40
P/OCF Ratio	51.55	51.62	37.87	46.70	53.93	41.13
PEG Ratio	4.01	2.78	2.95	3.38	3.13	2.94
EV/Sales Ratio	6.00	7.52	8.37	15.25	12.82	11.03
EV/EBITDA Ratio	18.46	24.08	23.34	46.34	39.52	36.13
EV/EBIT Ratio	19.91	26.10	25.16	50.28	42.74	38.73
EV/FCF Ratio	73.50	70.23	46.30	56.72	86.91	51.67
Debt / Equity Ratio	0.07	0.10	0.12	0.12	0.15	0.16
Debt / EBITDA Ratio	0.34	0.36	0.35	0.39	0.48	0.50
Debt / FCF Ratio	1.37	1.08	0.71	0.49	1.07	0.73
Asset Turnover	0.57	0.68	0.64	0.66	0.64	0.74
Inventory Turnover	1.38	1.35	1.35	1.63	1.50	1.79
Quick Ratio	2.70	2.08	1.87	2.07	2.24	2.34
Current Ratio	3.46	3.38	3.03	3.08	3.46	3.31
Return on Equity (ROE)	19.14%	22.34%	26.14%	28.88%	18.88%	28.73%
Return on Assets (ROA)	10.65%	12.25%	13.34%	12.60%	11.99%	13.11%
Return on Capital (ROIC)	13.41%	15.54%	17.20%	16.81%	16.30%	18.08%
Earnings Yield	10.00%	3.03%	3.30%	1.86%	1.45%	2.15%
FCF Yield	1.24%	1.39%	2.11%	1.74%	1.14%	1.91%
Buyback Yield / Dilution	1.35%	2.37%	1.11%	0.11%	0.75%	0.66%
Total Shareholder Return	1.35%	2.37%	1.11%	0.11%	0.75%	0.66%

Source: S&P Capital IQ. Standard template. Financial Sources.